C4 Therapeutics Presents Cemsidomide Biomarker Data in Multiple Myeloma
WATERTOWN, Mass. — September 25, 2026 C4 Therapeutics presented new biomarker data from clinical trials of cemsidomide in patients...
NK Cells
Advertisement
C4 Therapeutics to Present Cemsidomide Biomarker Data in Multiple Myeloma
Watertown, Mass., September 3, 2026 C4 Therapeutics announced that new biomarker data evaluating the immunomodulatory effects of cemsidomide in...
HCW Biologics Advances TGF-β/IL-15 Cancer Immunotherapy
Miramar, Fla. – August 25, 2026 HCW Biologics announced new findings supporting its TGF-β trap and IL-15 fusion moiety...
Telos Biotech and Made Scientific Partner to Advance TELOVANCE™ Evaluation
DALLAS, Texas & PRINCETON, N.J. | June 19, 2026 Telos Biotech, Inc. has announced a strategic evaluation collaboration with...
ImmunityBio Highlights ANKTIVA Data in Lung and Bladder Cancer at ASCO 2026
CULVER CITY, Calif., June 1, 2026 ImmunityBio announced new clinical and comparative data from its ANKTIVA® (nogapendekin alfa inbakicept-pmln)...
Advertisement
